Authors:
TONG AW
SU D
MUES G
TILLERY GW
GOLDSTEIN R
KLINTMALM G
STONE MJ
Citation: Aw. Tong et al., CHEMOSENSITIZATION OF HUMAN HEPATOCELLULAR-CARCINOMA CELLS WITH CYCLOSPORINE-A IN POST-LIVER TRANSPLANT PATIENT PLASMA, Clinical cancer research, 2(3), 1996, pp. 531-539
Citation: Aw. Tong et Mj. Stone, CD40 AND THE EFFECT OF ANTI-CD40-BINDING ON HUMAN MULTIPLE-MYELOMA CLONOGENICITY, Leukemia & lymphoma, 21(1-2), 1996, pp. 1-8
Citation: Bk. Seamour et al., DECREASED MULTIPLE-MYELOMA (MM) CELL-GROWTH FOLLOWING TRANSFECTION WITH AN INTERLEUKIN-6 (IL-6) PLASMID, The FASEB journal, 10(6), 1996, pp. 2021-2021
Authors:
ZHANG YA
NEUMUNAITIS J
MUES G
SCANLON KJ
TONG AW
Citation: Ya. Zhang et al., IN-VITRO SUPPRESSION OF HUMAN NON-SMALL-CELL LUNG-CANCER (NSCLC) CELL-GROWTH BY AN ANTI-K-RAS RIBOZYME, The FASEB journal, 10(6), 1996, pp. 2360-2360
Authors:
AMEGLIO F
ALVINO S
TRENTO E
MARCUCCI M
PIMPINELLI F
TONG AW
GANDOLFO GM
GRECO C
Citation: F. Ameglio et al., SERUM INTERLEUKIN-10 LEVELS IN PATIENTS AFFECTED WITH MULTIPLE-MYELOMA - CORRELATION WITH THE MONOCLONAL COMPONENT AND DISEASE PROGRESSION, International journal of oncology, 6(6), 1995, pp. 1189-1192
Authors:
TONG AW
HUANG YW
GHETIE V
NEMUNAITIS J
PINEIRO L
VITETTA E
STONE MJ
Citation: Aw. Tong et al., ENHANCEMENT OF ANTI-CD54 IMMUNOTOXIN CYTOTOXICITY TO HUMAN MULTIPLE-MYELOMA CELLS BY CYCLOSPORINE DRUGS, Blood, 84(10), 1994, pp. 10000170-10000170
Authors:
TONG AW
HUANG YW
ZHANG BQ
NETTO G
VITETTA ES
STONE MJ
Citation: Aw. Tong et al., HETEROTRANSPLANTATION OF HUMAN MULTIPLE-MYELOMA CELL-LINES IN SEVERE COMBINED IMMUNODEFICIENCY (SCID) MICE, Anticancer research, 13(3), 1993, pp. 593-598
Citation: Aw. Tong et al., EFFECT OF TREATMENT WITH CYCLOSPORINE-A AND THE P-GLYCOPROTEIN MONOCLONAL-ANTIBODY MRK-16 ON DOXORUBICIN CYTOTOXICITY IN CHEMORESISTANT MYELOMA CELL-LINES, Blood, 82(10), 1993, pp. 10000260-10000260